Sign Out
There is no indication for the use of Ovidrel during pregnancy. Data on a limited number of exposed pregnancies indicate no increased risks of malformation or foeto/neonatal toxicity. No reproduction studies with choriogonadotropin alfa in animals were performed. The potential risk for humans is unknown.
Breast-feeding: Ovidrel is not indicated during breast-feeding. There are no data on the excretion of choriogonadotropin alfa in milk.
Fertility: Ovidrel is indicated for use in infertility.
